MK7962-038_MERCK SOTERIA

Who Can Participate?

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)

Principal Investigator

Terry
Fortin

Protocol Number

PRO00118560

NCT ID

NCT07218029

Phase

III

Enrollment Status

Open to Enrollment